| human | Q5 |
| P496 | ORCID iD | 0000-0002-4478-9280 |
| P7293 | PLWABN ID | 9810660800105606 |
| P214 | VIAF ID | 7525148209316900460009 |
| P69 | educated at | Universidade do Extremo Sul Catarinense | Q2495752 |
| P108 | employer | Universidade Federal de Santa Catarina | Q1851075 |
| Regional University of Blumenau | Q10387863 | ||
| P734 | family name | Moretti | Q23039063 |
| Moretti | Q23039063 | ||
| Moretti | Q23039063 | ||
| P735 | given name | Morgana | Q20000632 |
| Morgana | Q20000632 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q39065318 | Agmatine enhances antidepressant potency of MK-801 and conventional antidepressants in mice |
| Q48240154 | Anti-HIV drugs nevirapine and efavirenz affect anxiety-related behavior and cognitive performance in mice. |
| Q48330773 | Antidepressant-like effect of Canavalia brasiliensis (ConBr) lectin in mice: evidence for the involvement of the glutamatergic system |
| Q47832884 | Antidepressant-like effect of ascorbic acid is associated with the modulation of mammalian target of rapamycin pathway |
| Q41562892 | Antidepressant-like effect of zinc is dependent on signaling pathways implicated in BDNF modulation |
| Q48454886 | Antidepressant-like effect of α-tocopherol in a mouse model of depressive-like behavior induced by TNF-α. |
| Q39363527 | Ascorbic Acid to Manage Psychiatric Disorders |
| Q48788833 | Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress |
| Q48849732 | Behavioral and neurochemical effects of sodium butyrate in an animal model of mania |
| Q43216299 | Blockade of adenosine A2A receptor counteracts neuropeptide-S-induced hyperlocomotion in mice |
| Q42645100 | DNA damage after intracerebroventricular injection of ouabain in rats |
| Q47811548 | Depressive-like behavior induced by tumor necrosis factor-α is abolished by agmatine administration |
| Q48078497 | Effects of Agmatine on Depressive-Like Behavior Induced by Intracerebroventricular Administration of 1-Methyl-4-phenylpyridinium (MPP(+)). |
| Q43174151 | Effects of a gastrin-releasing peptide receptor antagonist on D-amphetamine-induced oxidative stress in the rat brain |
| Q92971034 | Effects of cholecalciferol on behavior and production of reactive oxygen species in female mice subjected to corticosterone-induced model of depression |
| Q46074957 | Effects of long-term ovariectomy on anxiety and behavioral despair in rats |
| Q43231933 | Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain |
| Q42654013 | Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine |
| Q49020017 | Emotional behavior in middle-aged rats: Implications for geriatric psychopathologies |
| Q43243005 | Evaluation of brain creatine kinase activity in an animal model of mania induced by ouabain |
| Q47683528 | Evidence for the involvement of opioid system in the antidepressant-like effect of ascorbic acid. |
| Q46890312 | Folic acid prevents depressive-like behavior and hippocampal antioxidant imbalance induced by restraint stress in mice |
| Q48191591 | Folic acid prevents depressive-like behavior induced by chronic corticosterone treatment in mice. |
| Q45221876 | Histone deacetylase activity and brain-derived neurotrophic factor (BDNF) levels in a pharmacological model of mania |
| Q43162877 | Intracerebroventricular ouabain administration induces oxidative stress in the rat brain |
| Q62015523 | Involvement of different types of potassium channels in the antidepressant-like effect of ascorbic acid in the mouse tail suspension test |
| Q45892096 | Involvement of nitric oxide-cGMP pathway in the antidepressant-like effect of ascorbic acid in the tail suspension test |
| Q42971642 | Lithium and valproate modulate antioxidant enzymes and prevent ouabain-induced oxidative damage in an animal model of mania. |
| Q45926060 | Lithium attenuates behavioral and biochemical effects of neuropeptide S in mice. |
| Q48593874 | Long-term effects of ageing and ovariectomy on aversive and recognition memory and DNA damage in the hippocampus of female rats |
| Q37323300 | NMDA receptors and the L-arginine-nitric oxide-cyclic guanosine monophosphate pathway are implicated in the antidepressant-like action of the ethanolic extract from Tabebuia avellanedae in mice |
| Q46235953 | Neuropeptide S produces hyperlocomotion and prevents oxidative stress damage in the mouse brain: a comparative study with amphetamine and diazepam. |
| Q38155089 | Nutritional strategies for dealing with depression |
| Q46294346 | Preventive and therapeutic potential of ascorbic acid in neurodegenerative diseases |
| Q43659868 | Protective effects of ascorbic acid on behavior and oxidative status of restraint-stressed mice |
| Q38217524 | Role of agmatine in neurodegenerative diseases and epilepsy |
| Q37760462 | Role of oxidative stress in the pathophysiology of bipolar disorder. |
| Q42679245 | Sub-chronic agmatine treatment modulates hippocampal neuroplasticity and cell survival signaling pathways in mice. |
| Q47663689 | TNF-α-induced depressive-like phenotype and p38(MAPK) activation are abolished by ascorbic acid treatment |
| Q42753562 | Tamoxifen effects on respiratory chain complexes and creatine kinase activities in an animal model of mania |
Search more.